Terms: = Ovarian cancer AND LDH AND Treatment
61 results:
1. Sufficiently activated mature natural killer cells derived from peripheral blood mononuclear cells substantially enhance antitumor activity.
Liu C; Li Y; Li Y; Hu M; Wang H; Lu S; Li Z; Dilimulati D; Jiao S; Lu S; Zhao W
Immun Inflamm Dis; 2024 Jan; 12(1):e1143. PubMed ID: 38270321
[TBL] [Abstract] [Full Text] [Related]
2. High serum levels of inflammatory markers are associated with early recurrence in patients with high-grade serous ovarian cancer after platinum therapy.
Brzezinska B; Mysona DP; Richardson KP; Rungruang B; Hopkins D; Bearden G; Higgins R; Johnson M; Satter KB; McIndoe R; Ghamande S; Purohit S
Gynecol Oncol; 2023 Dec; 179():1-8. PubMed ID: 37862814
[TBL] [Abstract] [Full Text] [Related]
3. A retrospect study based on real-world data to observe metabolic function in cancer patients using albumin-bound paclitaxel.
Zheng Q; Wang H; Xue C; Yang S; Wang Y; Hou W; Zhang Y
Sci Rep; 2023 Jun; 13(1):9028. PubMed ID: 37270638
[TBL] [Abstract] [Full Text] [Related]
4. 6-Shogaol Overcomes Gefitinib Resistance via ER Stress in ovarian cancer Cells.
Kim TW; Lee HG
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768961
[TBL] [Abstract] [Full Text] [Related]
5. OTUD4-mediated GSDME deubiquitination enhances radiosensitivity in nasopharyngeal carcinoma by inducing pyroptosis.
Di M; Miao J; Pan Q; Wu Z; Chen B; Wang M; Zhao J; Huang H; Bai J; Wang Q; Tang Y; Li Y; He J; Xiang T; Weng D; Wang L; Xia J; Zhao C
J Exp Clin Cancer Res; 2022 Nov; 41(1):328. PubMed ID: 36411454
[TBL] [Abstract] [Full Text] [Related]
6. Primary leiomyosarcoma of ovary: A rare malignancy as an incidental finding.
Raychaudhuri S; Sidam D; Jain M; Chawla R; Pujani M; Wadhwa R
Indian J Pathol Microbiol; 2022; 65(4):938-941. PubMed ID: 36308213
[TBL] [Abstract] [Full Text] [Related]
7. Inhibition of the PIN1-NRF2/GPX4 axis imparts sensitivity to cisplatin in cervical cancer cells.
Zhang Z; Hu Q; Ye S; Xiang L
Acta Biochim Biophys Sin (Shanghai); 2022 Aug; 54(9):1325-1335. PubMed ID: 35983979
[TBL] [Abstract] [Full Text] [Related]
8. Bexarotene-induced cell death in ovarian cancer cells through Caspase-4-gasdermin E mediated pyroptosis.
Kobayashi T; Mitsuhashi A; Hongying P; Shioya M; Kojima K; Nishikimi K; Yahiro K; Shozu M
Sci Rep; 2022 Jul; 12(1):11123. PubMed ID: 35778597
[TBL] [Abstract] [Full Text] [Related]
9. Organoantimony (III) Derivative Induces Necroptosis in Human Breast cancer MDA-MB-231 Cells.
Liu YP; Lei J; Yin MM; Chen Y
Anticancer Agents Med Chem; 2022; 22(13):2448-2457. PubMed ID: 35040419
[TBL] [Abstract] [Full Text] [Related]
10. Anticancer effects of asiatic acid against doxorubicin-resistant breast cancer cells via an AMPK-dependent pathway in vitro.
Zhu Z; Cui L; Yang J; Vong CT; Hu Y; Xiao J; Chan G; He Z; Zhong Z
Phytomedicine; 2021 Nov; 92():153737. PubMed ID: 34560519
[TBL] [Abstract] [Full Text] [Related]
11. Efficacy and safety of anti-PD-1-based therapy in combination with PARP inhibitors for patients with advanced solid tumors in a real-world setting.
Wu Z; Tao H; Zhang S; Wang X; Ma J; Li R; Liu Z; Wang J; Cui P; Chen S; Di H; Huang Z; Zheng X; Hu Y
Cancer Immunol Immunother; 2021 Oct; 70(10):2971-2980. PubMed ID: 33740125
[TBL] [Abstract] [Full Text] [Related]
12. Inhibitory Effects of Digoxin and Digitoxin on Cell Growth in Human ovarian cancer Cell Line SKOV-3.
Chou JC; Li JH; Chen CC; Chen CW; Lin H; Wang PS
Integr Cancer Ther; 2021; 20():15347354211002662. PubMed ID: 33736483
[TBL] [Abstract] [Full Text] [Related]
13. Anti-cancer Tumor Cell Necrosis of Epithelial ovarian cancer Cell Lines Depends on High Expression of HDM-2 Protein in Their Membranes.
Thadi A; Gleeson EM; Khalili M; Shaikh MF; Goldstein E; Morano WF; Daniels LM; Grandhi N; Glatthorn H; Richard SD; Campbell PM; Sarafraz-Yazdi E; Pincus MR; Bowne WB
Ann Clin Lab Sci; 2020 Sep; 50(5):611-624. PubMed ID: 33067207
[TBL] [Abstract] [Full Text] [Related]
14. 1-MT inhibits the invasion of CBP-resistant ovarian cancer cells via down-regulating IDO expression and re-activating immune cells function.
Ma H; Qin Q; Mi J; Feng Q
BMC Pharmacol Toxicol; 2020 Sep; 21(1):67. PubMed ID: 32912307
[TBL] [Abstract] [Full Text] [Related]
15. Gynecologic cancer in pregnancy.
Korenaga TK; Tewari KS
Gynecol Oncol; 2020 Jun; 157(3):799-809. PubMed ID: 32268951
[TBL] [Abstract] [Full Text] [Related]
16. Simple
Fabijańska M; Orzechowska M; Rybarczyk-Pirek AJ; Dominikowska J; Bieńkowska A; Małecki M; Ochocki J
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32204470
[TBL] [Abstract] [Full Text] [Related]
17. Therapeutic potential of combination therapy of soluble VEGF receptor 1 and conventional chemotherapy for ovarian cancer growth.
Sato N; Kumasawa K; Yamashita M; Miyake T; Nakamura H; Kimura T
J Obstet Gynaecol Res; 2020 Apr; 46(4):636-645. PubMed ID: 32022375
[TBL] [Abstract] [Full Text] [Related]
18. Vitamin C supplementation had no side effect in non-cancer, but had anticancer properties in ovarian cancer cells.
Gregoraszczuk EL; Zajda K; Tekla J; Respekta N; Zdybał P; Such A
Int J Vitam Nutr Res; 2021 Jun; 91(3-4):293-303. PubMed ID: 32008465
[No Abstract] [Full Text] [Related]
19. Exendin-4 Induces Cytotoxic Autophagy in Two ovarian cancer Cell Lines through Inhibition of Mtorc1 Mediated by Activation of AMPK and Suppression of Akt.
Badi RM; Khaleel EF; El-Bidawy MH; Satti HH; Mostafa DG
Folia Biol (Praha); 2020; 66(5-6):186-203. PubMed ID: 34087975
[TBL] [Abstract] [Full Text] [Related]
20. The Destruction Of Laser-Induced Phase-Transition Nanoparticles Triggered By Low-Intensity Ultrasound: An Innovative Modality To Enhance The Immunological treatment Of ovarian cancer Cells.
Xie W; Zhu S; Yang B; Chen C; Chen S; Liu Y; Nie X; Hao L; Wang Z; Sun J; Chang S
Int J Nanomedicine; 2019; 14():9377-9393. PubMed ID: 31819438
[TBL] [Abstract] [Full Text] [Related]
[Next]
